{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:05:52Z","timestamp":1793675152403,"version":"4.5.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Siriraj Research Fund, Faculty of Medicine Siriraj Hospital, Mahidol university","award":["R016232023"],"award-info":[{"award-number":["R016232023"]}],"id":[{"id":"https:\/\/ror.org\/01znkr924","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Current treatment of severe dry eye disease (DED) includes blood-derived eye drops, such as autologous serum (AS), which lubricate the eyes and provide factors that improve ocular surface and aid in wound healing. Recent studies indicated that platelet-rich plasma (PRP) was also effective. This study aims to compare the concentration and stability of epitheliotrophic factors in AS and PRP and their efficacy in DED patients. Epitheliotrophic factors of interest are epidermal growth factor (EGF), fibronectin, platelet-derived growth factor-AB (PDGF-AB), and transforming growth factor-beta1 (TGF-\u03b21). We determined that all epitheliotrophic factors were present in AS and PRP at baseline and did not decrease in concentrations in all storage conditions (4\u00a0\u00b0C for 1\u00a0week and at\u2009\u2212\u200920\u00a0\u00b0C for 1 and 3\u00a0months). However, differences in concentrations in AS and PRP were observed. PRP was also shown not to be inferior to AS in terms of efficacy in DED treatment in a prospective randomized control trial which evaluated ocular surface disease index, dry eye questionnaire, ocular surface staining, tear breakup time, and Schirmer test at baseline and at 1-month follow-up. Therefore, with its shorter preparation time, PRP could be considered as an alternative to AS for the treatment of DED.<\/jats:p>","DOI":"10.1038\/s41598-022-12879-x","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T06:11:07Z","timestamp":1653545467000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Comparison of epitheliotrophic factors in platelet-rich plasma versus autologous serum and their treatment efficacy in dry eye disease"],"prefix":"10.1038","volume":"12","author":[{"given":"Chanatip","family":"Metheetrairut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panotsom","family":"Ngowyutagon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhirak","family":"Tunganuntarat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladawan","family":"Khowawisetsut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kulvara","family":"Kittisares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinnita","family":"Prabhasawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,26]]},"reference":[{"key":"12879_CR1","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","volume":"15","author":"F Stapleton","year":"2017","unstructured":"Stapleton, F. et al. TFOS DEWS II epidemiology report. Ocul. Surf. 15, 334\u2013365. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.003 (2017).","journal-title":"Ocul. Surf."},{"key":"12879_CR2","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.ajo.2014.11.028","volume":"159","author":"R van der Vaart","year":"2015","unstructured":"van der Vaart, R., Weaver, M. A., Lefebvre, C. & Davis, R. M. The association between dry eye disease and depression and anxiety in a large population-based study. Am. J. Ophthalmol. 159, 470\u2013474. https:\/\/doi.org\/10.1016\/j.ajo.2014.11.028 (2015).","journal-title":"Am. J. Ophthalmol."},{"key":"12879_CR3","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","volume":"15","author":"L Jones","year":"2017","unstructured":"Jones, L. et al. TFOS DEWS II management and therapy report. Ocul. Surf. 15, 575\u2013628. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.006 (2017).","journal-title":"Ocul. Surf."},{"key":"12879_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ophtha.2019.08.018","volume":"127","author":"RM Shtein","year":"2020","unstructured":"Shtein, R. M. et al. Autologous serum-based eye drops for treatment of ocular surface disease: A report by the American Academy of Ophthalmology. Ophthalmology 127, 128\u2013133. https:\/\/doi.org\/10.1016\/j.ophtha.2019.08.018 (2020).","journal-title":"Ophthalmology"},{"key":"12879_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ajo.2018.02.009","volume":"189","author":"TK Ali","year":"2018","unstructured":"Ali, T. K. et al. Use of autologous serum tears for the treatment of ocular surface disease from patients with systemic autoimmune diseases. Am. J. Ophthalmol. 189, 65\u201370. https:\/\/doi.org\/10.1016\/j.ajo.2018.02.009 (2018).","journal-title":"Am. J. Ophthalmol."},{"key":"12879_CR6","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s00417-014-2599-1","volume":"252","author":"AR Celebi","year":"2014","unstructured":"Celebi, A. R., Ulusoy, C. & Mirza, G. E. The efficacy of autologous serum eye drops for severe dry eye syndrome: A randomized double-blind crossover study. Graefes Arch. Clin. Exp. Ophthalmol. 252, 619\u2013626. https:\/\/doi.org\/10.1007\/s00417-014-2599-1 (2014).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"12879_CR7","doi-asserted-by":"publisher","DOI":"10.5935\/0034-7280.20170067","author":"MVMR Ribeiro","year":"2017","unstructured":"Ribeiro, M. V. M. R. et al. The use of platelet rich-plasma in Ophthalmology: A literature review. Rev. Bras. de Oftalmol. https:\/\/doi.org\/10.5935\/0034-7280.20170067 (2017).","journal-title":"Rev. Bras. de Oftalmol."},{"key":"12879_CR8","doi-asserted-by":"publisher","first-page":"e170","DOI":"10.1111\/aos.13907","volume":"97","author":"V Garc\u00eda-Conca","year":"2019","unstructured":"Garc\u00eda-Conca, V. et al. Efficacy and safety of treatment of hyposecretory dry eye with platelet-rich plasma. Acta Ophthalmol. 97, e170\u2013e178. https:\/\/doi.org\/10.1111\/aos.13907 (2019).","journal-title":"Acta Ophthalmol."},{"key":"12879_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000100933","volume":"39","author":"JL Alio","year":"2007","unstructured":"Alio, J. L., Colecha, J. R., Pastor, S., Rodriguez, A. & Artola, A. Symptomatic dry eye treatment with autologous platelet-rich plasma. Ophthalmic Res. 39, 124\u2013129. https:\/\/doi.org\/10.1159\/000100933 (2007).","journal-title":"Ophthalmic Res."},{"key":"12879_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s40123-017-0100-z","volume":"6","author":"JL Alio","year":"2017","unstructured":"Alio, J. L., Rodriguez, A. E., Ferreira-Oliveira, R., Wr\u00f3bel-Dudzi\u0144ska, D. & Abdelghany, A. A. Treatment of dry eye disease with autologous platelet-rich plasma: A prospective, interventional, non-randomized study. Ophthalmol. Therapy 6, 285\u2013293. https:\/\/doi.org\/10.1007\/s40123-017-0100-z (2017).","journal-title":"Ophthalmol. Therapy"},{"key":"12879_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1590\/S0004-27492008000700010","volume":"71","author":"GG Quinto","year":"2008","unstructured":"Quinto, G. G., Campos, M. & Behrens, A. Autologous serum for ocular surface diseases. Arq. Bras. Oftalmol. 71, 47\u201354 (2008).","journal-title":"Arq. Bras. Oftalmol."},{"key":"12879_CR12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1755-3768.1992.tb02170.x","volume":"70","author":"G Schultz","year":"1992","unstructured":"Schultz, G., Chegini, N., Grant, M., Khaw, P. & MacKay, S. Effects of growth factors on corneal wound healing. Acta Ophthalmol. Suppl. 70, 60\u201366. https:\/\/doi.org\/10.1111\/j.1755-3768.1992.tb02170.x (1992).","journal-title":"Acta Ophthalmol. Suppl."},{"key":"12879_CR13","doi-asserted-by":"publisher","first-page":"e605","DOI":"10.1111\/aos.12710","volume":"93","author":"E Anitua","year":"2015","unstructured":"Anitua, E. et al. Autologous serum and plasma rich in growth factors in ophthalmology: Preclinical and clinical studies. Acta Ophthalmol. 93, e605\u2013e614. https:\/\/doi.org\/10.1111\/aos.12710 (2015).","journal-title":"Acta Ophthalmol."},{"key":"12879_CR14","first-page":"1691","volume":"42","author":"S Hayashida-Hibino","year":"2001","unstructured":"Hayashida-Hibino, S. et al. The effect of TGF-beta1 on differential gene expression profiles in human corneal epithelium studied by cDNA expression array. Investig. Ophthalmol. Vis. Sci. 42, 1691\u20131697 (2001).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"12879_CR15","first-page":"46","volume":"54","author":"B Strzalka","year":"2008","unstructured":"Strzalka, B. et al. Quantitative analysis of transforming growth factor beta isoforms mRNA in the human corneal epithelium. Folia Biol. (Praha) 54, 46\u201352 (2008).","journal-title":"Folia Biol. (Praha)"},{"key":"12879_CR16","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/jcp.1041450323","volume":"145","author":"T Nishida","year":"1990","unstructured":"Nishida, T., Nakamura, M., Mishima, H. & Otori, T. Differential modes of action of fibronectin and epidermal growth factor on rabbit corneal epithelial migration. J. Cell Physiol. 145, 549\u2013554. https:\/\/doi.org\/10.1002\/jcp.1041450323 (1990).","journal-title":"J. Cell Physiol."},{"key":"12879_CR17","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1001\/archopht.1984.01040030369040","volume":"102","author":"T Nishida","year":"1984","unstructured":"Nishida, T., Nakagawa, S., Nishibayashi, C., Tanaka, H. & Manabe, R. Fibronectin enhancement of corneal epithelial wound healing of rabbits in vivo. Arch. Ophthalmol. 102, 455\u2013456. https:\/\/doi.org\/10.1001\/archopht.1984.01040030369040 (1984).","journal-title":"Arch. Ophthalmol."},{"key":"12879_CR18","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/s0886-3350(02)01609-7","volume":"29","author":"G Schmidinger","year":"2003","unstructured":"Schmidinger, G. et al. Effect of tenascin and fibronectin on the migration of human corneal fibroblasts. J. Cataract Refract. Surg. 29, 354\u2013360. https:\/\/doi.org\/10.1016\/s0886-3350(02)01609-7 (2003).","journal-title":"J. Cataract Refract. Surg."},{"key":"12879_CR19","first-page":"1364","volume":"40","author":"WJ Kim","year":"1999","unstructured":"Kim, W. J., Mohan, R. R., Mohan, R. R. & Wilson, S. E. Effect of PDGF, IL-1alpha, and BMP2\/4 on corneal fibroblast chemotaxis: Expression of the platelet-derived growth factor system in the cornea. Investig. Ophthalmol. Vis. Sci. 40, 1364\u20131372 (1999).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"12879_CR20","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.exer.2015.02.016","volume":"135","author":"E Anitua","year":"2015","unstructured":"Anitua, E. et al. Plasma rich in growth factors (PRGF) eye drops stimulates scarless regeneration compared to autologous serum in the ocular surface stromal fibroblasts. Exp. Eye Res. 135, 118\u2013126. https:\/\/doi.org\/10.1016\/j.exer.2015.02.016 (2015).","journal-title":"Exp. Eye Res."},{"key":"12879_CR21","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s10384-012-0175-y","volume":"56","author":"KM Kim","year":"2012","unstructured":"Kim, K. M., Shin, Y. T. & Kim, H. K. Effect of autologous platelet-rich plasma on persistent corneal epithelial defect after infectious keratitis. Jpn. J. Ophthalmol. 56, 544\u2013550. https:\/\/doi.org\/10.1007\/s10384-012-0175-y (2012).","journal-title":"Jpn. J. Ophthalmol."},{"key":"12879_CR22","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1097\/ICO.0b013e31829f7088","volume":"32","author":"E Anitua","year":"2013","unstructured":"Anitua, E. et al. Biological stability of plasma rich in growth factors eye drops after storage of 3 months. Cornea 32, 1380\u20131386 (2013).","journal-title":"Cornea"},{"key":"12879_CR23","doi-asserted-by":"publisher","first-page":"799","DOI":"10.7205\/milmed-d-13-00336","volume":"179","author":"JR Evanson","year":"2014","unstructured":"Evanson, J. R. et al. Gender and age differences in growth factor concentrations from platelet-rich plasma in adults. Mil. Med. 179, 799\u2013805. https:\/\/doi.org\/10.7205\/milmed-d-13-00336 (2014).","journal-title":"Mil. Med."},{"key":"12879_CR24","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3109\/02713683.2011.587935","volume":"36","author":"N Phasukkijwatana","year":"2011","unstructured":"Phasukkijwatana, N., Lertrit, P., Liammongkolkul, S. & Prabhasawat, P. Stability of epitheliotrophic factors in autologous serum eye drops from chronic Stevens-Johnson syndrome dry eye compared to non-autoimmune dry eye. Curr. Eye Res. 36, 775\u2013781. https:\/\/doi.org\/10.3109\/02713683.2011.587935 (2011).","journal-title":"Curr. Eye Res."},{"key":"12879_CR25","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/j.1442-9071.2008.01895.x","volume":"36","author":"JC Bradley","year":"2008","unstructured":"Bradley, J. C., Bradley, R. H., McCartney, D. L. & Mannis, M. J. Serum growth factor analysis in dry eye syndrome. Clin. Exp. Ophthalmol. 36, 717\u2013720. https:\/\/doi.org\/10.1111\/j.1442-9071.2008.01895.x (2008).","journal-title":"Clin. Exp. Ophthalmol."},{"key":"12879_CR26","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1167\/iovs.13-13000","volume":"55","author":"M Kaido","year":"2014","unstructured":"Kaido, M. et al. Dry-eye screening by using a functional visual acuity measurement system: The Osaka Study. Investig. Ophthalmol. Vis. Sci. 55, 3275\u20133281. https:\/\/doi.org\/10.1167\/iovs.13-13000 (2014).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"12879_CR27","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","volume":"22","author":"AJ Bron","year":"2003","unstructured":"Bron, A. J., Evans, V. E. & Smith, J. A. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 22, 640\u2013650. https:\/\/doi.org\/10.1097\/00003226-200310000-00008 (2003).","journal-title":"Cornea"},{"key":"12879_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1167\/tvst.9.6.22","volume":"9","author":"AE Rodriguez","year":"2020","unstructured":"Rodriguez, A. E., Gisbert, S., Palaz\u00f3n, A. & Alio, J. L. Quantification of growth factors and fibronectin in diverse preparations of platelet-rich plasma for the treatment of ocular surface disorders (E-PRP). Transl. Vis. Sci. Technol. 9, 22. https:\/\/doi.org\/10.1167\/tvst.9.6.22 (2020).","journal-title":"Transl. Vis. Sci. Technol."},{"key":"12879_CR29","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1097\/ICO.0b013e31829f7088","volume":"32","author":"E Anitua","year":"2013","unstructured":"Anitua, E., Muruzabal, F., Pino, A., Merayo-Lloves, J. & Orive, G. Biological stability of plasma rich in growth factors eye drops after storage of 3 months. Cornea 32, 1380\u20131386. https:\/\/doi.org\/10.1097\/ICO.0b013e31829f7088 (2013).","journal-title":"Cornea"},{"key":"12879_CR30","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.jcms.2018.10.017","volume":"47","author":"D Steller","year":"2019","unstructured":"Steller, D., Herbst, N., Pries, R., Juhl, D. & Hakim, S. G. Impact of incubation method on the release of growth factors in non-Ca(2+)-activated PRP, Ca(2+)-activated PRP, PRF and A-PRF. J. Craniomaxillofac. Surg. 47, 365\u2013372. https:\/\/doi.org\/10.1016\/j.jcms.2018.10.017 (2019).","journal-title":"J. Craniomaxillofac. Surg."},{"key":"12879_CR31","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/jor.24520","volume":"38","author":"JI Kim","year":"2020","unstructured":"Kim, J. I., Bae, H. C., Park, H. J., Lee, M. C. & Han, H. S. Effect of storage conditions and activation on growth factor concentration in platelet-rich plasma. J. Orthop. Res. 38, 777\u2013784. https:\/\/doi.org\/10.1002\/jor.24520 (2020).","journal-title":"J. Orthop. Res."},{"key":"12879_CR32","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1136\/bjsports-2012-091916","volume":"49","author":"B Hamilton","year":"2015","unstructured":"Hamilton, B., Tol, J. L., Knez, W. & Chalabi, H. Exercise and the platelet activator calcium chloride both influence the growth factor content of platelet-rich plasma (PRP): Overlooked biochemical factors that could influence PRP treatment. Br. J. Sports Med. 49, 957\u2013960. https:\/\/doi.org\/10.1136\/bjsports-2012-091916 (2015).","journal-title":"Br. J. Sports Med."},{"key":"12879_CR33","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1177\/0363546519827294","volume":"47","author":"P Jayaram","year":"2019","unstructured":"Jayaram, P. et al. Effects of aspirin on growth factor release from freshly isolated leukocyte-rich platelet-rich plasma in healthy men: A prospective fixed-sequence controlled laboratory study. Am. J. Sports Med. 47, 1223\u20131229. https:\/\/doi.org\/10.1177\/0363546519827294 (2019).","journal-title":"Am. J. Sports Med."},{"key":"12879_CR34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1136\/bjophthalmol-2013-304801","volume":"99","author":"S Mukhopadhyay","year":"2015","unstructured":"Mukhopadhyay, S., Sen, S. & Datta, H. Comparative role of 20% cord blood serum and 20% autologous serum in dry eye associated with Hansen\u2019s disease: A tear proteomic study. Br. J. Ophthalmol. 99, 108\u2013112. https:\/\/doi.org\/10.1136\/bjophthalmol-2013-304801 (2015).","journal-title":"Br. J. Ophthalmol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12879-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12879-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12879-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T23:00:00Z","timestamp":1669330800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12879-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,26]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["12879"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-12879-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,26]]},"assertion":[{"value":"11 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8906"}}